Global Sciatica Treatment Market Report 2019-2023 with Market Positioning of Key Vendors – Bayer, Johnson & Johnson, Novartis, Pfizer & Teva Pharmaceuticals – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global
Sciatica Treatment Market 2019-2023” report has been added to ResearchAndMarkets.com’s
offering.

The analysts have predicted that the sciatica treatment market will
register a close to 8% by 2023.

Sciatica is often confused with general back pain. Sciatica can cause
long-term pain in the lower back if the condition is left untreated.
Hence, various government and non-governmental organizations are
initiating certain programs to increase awareness among people about the
condition and avoid delay in diagnosis.

For instance, Ortholnfo, the patient education site of the American
Academy of Orthopaedic Surgeons (AAOS), is providing awareness about
sciatica through articles, videos, and animations in the US. Similarly,
initiative from different countries are providing comprehensive and
relevant health information related to various hearth-related problems,
including sciatica. Such increasing awareness programs help patients to
know about the disease and available safe treatment options, which are
expected to drive market growth during the forecast period.

Market Overview

Growing prevalence of risk factors for sciatica

Although sciatica occurs more commonly due to spinal cord injuries. It
also occurs due to disease conditions such as lumbar spinal stenosis,
osteoarthritis, spondylolisthesis, and muscle spasms. Hence, an increase
in the number of patients with these diseases may increase the chances
of development of sciatica. This, in turn, is expected to aid in the use
of available and anticipated treatments and drive the growth of the
global sciatica treatment market during the forecast period.

Lack of approved treatments

Most of the patients benefit from this combination of treatment methods
such as epidural injections of corticosteroids, physiotherapy, and
bracing. However, there is no approved treatment for sciatica.
Therefore, the lack of approved treatments for sciatica is expected to
hamper the growth of the global sciatica treatment market during the
forecast period.

Competitive Landscape

The market appears to be highly fragmented and with the presence of
several vendors. This market research report will help clients identify
new growth opportunities and design unique growth strategies by
providing a comprehensive analysis of the market’s competitive landscape
and offering information on the products offered by companies.

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 04: MARKET SIZING

• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 06: PIPELINE

PART 07: MARKET SEGMENTATION BY TYPE

• Market segmentation by type
• Comparison by type
• Non-surgical treatment – Market size and forecast 2018-2023
• Surgical treatment – Market size and forecast 2018-2023
• Market opportunity by type

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

• Geographic segmentation
• Geographic comparison
• Key leading countries
• Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

• Market drivers
• Market challenges

PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE

• Overview
• Landscape disruption
• Competitive scenario

PART 14: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Bayer AG
• Johnson & Johnson Services, Inc.
• Novartis AG
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.

PART 15: APPENDIX

For more information about this report visit https://www.researchandmarkets.com/r/j89596

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Musculoskeletal
Disorders Drugs